Merck Names New Managers for Chemicals Divisions

12-Oct-2007 - Merck announced that it has realigned the leadership of its Chemicals divisions. The current Head of Liquid Crystals, Dr. Paul Breddels (51), has decided to leave the company for personal reasons. As of November 1, 2007, Walter Galinat, currently Head of the Performance & Life Science Chemicals ...

Merck Successfully Replaces EUR 2 billion Multi-Currency Revolving Credit Facility

08-Oct-2007 - Merck KGaA announced that it has successfully completed the syndication of a new EUR 2 billion multi-currency revolving credit facility. The credit facility will be used for general corporate purposes and has a seven-year tenor. The facility will replace the existing EUR 2 billion multi-currency ...

Merck Completes Sale of Generics Business to Mylan for EUR 4.9 Billion

05-Oct-2007 - Merck KGaA announced that it has completed the sale of its worldwide Generics business to Mylan Laboratories Inc. Closing was accomplished via a purchase agreement whereby Mylan acquired all Merck Generics companies throughout the world for EUR 4.9 billion. Proceeds of the sale will be booked in ...

Delisting of Merck Serono shares expected on July 18, 2007

Squeeze Out Successfully Completed

10-Jul-2007 - The Civil Court of Basel has cancelled all remaining publicly held shares of Merck Serono S.A. (Merck Serono) and annulled all outstanding rights to acquire such shares. Therefore, Merck now holds 100% of the shares of Merck Serono. Merck Serono's shares will be delisted from the SWX Swiss ...

Merck Signs Strategic Alliance With Archemix

13-Jun-2007 - Merck KGaA announced that it has formed a multi-year strategic alliance between its Merck Serono division and Archemix Corp. of Cambridge, Massachusetts, to discover, develop and commercialize first-in-class aptamer therapeutics with a primary focus on the treatment of cancer. Additional areas of ...

Merck Sells Generics Business to Mylan for EUR 4.9 Billion

15-May-2007 - Merck KGaA announced that it will sell its Generics business to Mylan Laboratories Inc, Canonsburg, PA USA. Merck and Mylan have signed a share purchase agreement whereby Mylan will acquire all Merck Generics companies throughout the world for EUR 4.9 billion. The divested Generics business ...

Heinrich Emanuel Merck Award 2007 Goes to Two Leading Scientists

03-Apr-2007 - The Heinrich Emanuel Merck Award 2007 for Analytical Chemistry will be bestowed this year on two leading scientists - Professor Dr. Shuming Nie, the Wallace H. Coulter Distinguished Chair Professor of Biomedical Engineering (Emory University and Georgia Institute of Technology, Atlanta, USA), and ...

Merck KGaA und TU Darmstadt wagen "Chemieexperiment"

Gemeinsames Schülerlabor an der Uni mit umfangreichem Angebot

26-Mar-2007 - Die Technische Universität Darmstadt und Merck KGaA investieren in ein gemeinschaftliches Schülerlabor, um noch mehr Begeisterung und Verständnis für Naturwissenschaften zu wecken, den Nachwuchs gezielt und praxisnah zu fördern und um ein Angebot zur Fortbildung von Lehrkräften zu bieten. Es ist ...

ChemDiv to provide Merck KGaA with discovery chemistry in multiyear agreement, extending ongoing collaboration

19-Feb-2007 - ChemDiv, Inc. announced that Merck KGaA has renewed and expanded on an agreement with ChemDiv as its preferred provider of discovery libraries of lead-like small molecules through 2009. The new agreement expands the collaboration that has been going on for the last three years, and roughly ...

Merck KGaA to Explore Divestiture of Its Generics Business

09-Jan-2007 - Merck KGaA confirmed, that it is evaluating the divestiture of its Generics division (Merck Generics) as one strategic option. Merck is not engaged in initial discussions with any potential buyers. Irrespective of this strategic evaluation Merck still plans to make a capital increase of EUR 2 ...